Company Overview
Manufacture and sale of Cochlear implant systems.
Website | www.cochlear.com |
---|---|
Head Office | Macquarie University NSW |
Registry | Computershare Investor Services |
CEO | Dig Howitt |
Chair Person | Catriona Deans |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Equipment |
Sector | Health Care |
Market Cap | $15,346 b |
---|---|
Shares on Issue | 65 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Ms Christine Frances McLoughlin
Non-Executive Director 01/11/2020
Ms McLoughlin has served on the boards of a number of ASX50 companies and is a company director with domestic and international experience. She has had wide ranging experience covering health, insurance, resources, infrastructure and financial services. In June 2021, Ms McLoughlin was awarded a Member of the Order of Australia in the Queen's Birthday Honours for her services to business, the not-for-profit sector and women. Other boards includes Chairman of the Suncorp Group Limited, Chancellor of the University of Wollongong. Chairman, Destination NSW. Australian Private Sector Representative, G20 EMPOWER Council. Former directorships includes NIB Holding, the McGrath Foundation and Venues NSW. She is member of Risk, People & Culture Committees.
BA, LLB (Hon), FAICD, MCEW Female
Mr Michael Grenfell Daniell
Non-Executive Director 01/01/2020
Mr Daniell has 40 years experience in the medical device industry with executive leadership experience. Former Managing Director and CEO of Fisher & Paykel Healthcare Corporation Limited responsible for the global business and operations including the design, manufacture and marketing of innovative products and systems for use in respiratory care, acute care and treatment of obstructive sleep apnea. In June 2021, Sir Michael was made a Knight Companion of the New Zealand Order of Merit for his services to business, healthcare and governance. Other boards includes Director, Fisher & Paykel Healthcare Corporation Ltd, Council member, The University of Auckland, Director, Tait International Limited, Chair, New Zealand Medical Technology Centre of Research Excellence, Director, Medical Research Commercialisation Fund. He is Chair of Technology & Innovation Committee effective 20 August 2021. Member of the Medical Science and Technology & Innovation Committees.
BE(Electrical Eng-Hons) Engineer Male
Ms Catriona Alison Deans
Non-Executive Director,Non-Executive Chairman 01/01/2015
Ms Deans have experience leading technology enabled businesses across ecommerce, media and financial services. Former Chief Executive Officer of netus, Hoyts Cinemas, ecorp and eBay Australia and New Zealand. Other boards includes Director, Ramsay Health Care Limited and Deputy Group Pty Ltd. Senior Advisor to McKinsey & Company. Member of Investment Committee, CSIRO Innovation fund (MainSequence Ventures) and member of AICD Corporate Governance Committee. Director of SCEGGS Darlinghurst Limited and The Observership Program. Former directorships includes Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. She is Chair Technology & Innovation Committee until 19 August 2021. Member of the Risk and People & Culture Committees.
BA, MBA, GAICD, MA(Natural Sci) Female
Mr Andrew Leslie Denver
Non-Executive Director 01/02/2007
Mr Denver have experience in the life sciences industry. Former Managing Director of Memtec Limited and President Asia for Pall Corporation. He is Chairman of SpeeDx and Director, Vaxxas and QBiotics and was Executive Chairman of Universal Biosensors. He is member of Risk, Medical Science, Technology & Innovation and Committees.
BSc (Chem,Hons), MBA, FAICD Male
Ms Yasmin Anita Allen
Non-Executive Director 02/08/2010
Ms Allen has career in investment banking with senior roles in strategic analysis and corporate advice. Former Vice President of Deutsche Bank AG, Director of ANZ Investment Bank and Associate Director of HSBC London. She is also Chair of Australian Federal Government Steering Group for Digital Skills Organisation. She is Director of Santos Limited, ASX Limited and National Portrait Gallery. Member of the George Institute for Global Health Board. Chairman, Advance (Global Australian Network), Acting President, Australian Government Takeovers Panel and Chairman of Faethm.org. She is Chair of the Risk Committee, Member of the People & Culture and Technology & Innovation Committees. She was director of Insurance Australia Group Limited, National director of the Australian Institute of Company Directors, Member of The Salvation Army Advisory Board. Chair of Macquarie Specialised Asset Management.
BCom, FAICD Female
Mr Glen Francis Boreham
Non-Executive Director 01/01/2015
Mr Boreham led organisations in information technology, new media and the creative industries through periods of rapid change and innovation. Former Managing Director of IBM Australia and New Zealand. He is Director of Southern Cross Media Group and Link Group and Strategic Advisor of IXUP. He was director of Data#3. Chairman of Screen Australia, Advance (Global Australian Network), Business School and Industry Advisory Board for the University of Technology, Sydney and Advisory Board IXUP. He is Chair of the People & Culture Committee. Member of the Risk and Technology & Innovation Committees.
AM, BEcon, FAICD,AO, Hon DT Male
Professor Bruce Gregory Robinson
Non-Executive Director 13/12/2016
Prof Robinson have 20 years leadership experience as an academic physician/scientist across research, healthcare and medicine, and tertiary education. Former Dean of The University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. Other boards includes Chairman, National Health and Medical Research Council. Director, MaynePharma, QBiotocs and Ecofibre. Director, Woolcock Institute of Medical Research and Senior Advisor to McKinsey & Company and MinterEllison. Former directorships includes Chairman, Medical Benefits Schedule Review Taskforce. Director, Lorica Health Pty Limited, Firefly and Digital Health Agency CRC. He is Chair of Medical Science Committee. Member of the People & Culture and Technology & Innovation Committees.
AC,MD, MSc, FRACP, FAAHMS, FAICD Physician and Scientist Male
Mr Dig Howitt
President,Chief Executive Officer,Managing Director 31/07/2017
Mr Howitt has experience across the Company in roles including Chief Operating Officer, SVP, Manufacturing and Logistics and President, Asia Pacific. Prior to joining Cochlear, worked for Boral and Boston Consulting Group. Dig is a member of the Champions of Change STEM group. He is Member of the Medical Science and Technology & Innovation Committees. He is Director of QPBT Pty Ltd.
BE(Hons),MBA Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | HSBC Custody Nominees (Australia) Limited | 30,209,511 | 45.95 |
2. | J P Morgan Nominees Australia Pty Limited | 9,708,153 | 14.77 |
3. | Citicorp Nominees Pty Limited | 3,911,642 | 5.95 |
4. | National Nominees Limited | 1,606,824 | 2.44 |
5. | BNP Paribas Noms Pty Ltd <Drp> | 1,570,432 | 2.39 |
6. | BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> | 1,166,640 | 1.77 |
7. | HSBC Custody Nominees (Australia) Limited GSCO ECA | 645,315 | 0.98 |
8. | BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> | 486,754 | 0.74 |
9. | HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 373,306 | 0.57 |
10. | Australian Foundation Investment Company Limited | 324,174 | 0.49 |
11. | Netwealth Investments Limited <Wrap Services A/C> | 258,114 | 0.39 |
12. | Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 222,299 | 0.34 |
13. | Mr Christopher Graham Roberts | 172,387 | 0.26 |
14. | BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> | 120,873 | 0.18 |
15. | Custodial Services Limited <Beneficiaries Holding A/C> | 117,587 | 0.18 |
16. | HSBC Custody Nominees (Australia) Limited A/C 2 | 94,699 | 0.14 |
17. | AMP Life Limited | 80,692 | 0.12 |
18. | BNP Paribas Nominees Pty Ltd Acf Clearstream | 65,891 | 0.10 |
19. | National Nominees Limited <N A/C> | 57,163 | 0.09 |
20. | BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> | 55,055 | 0.08 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
30/09/2021 | Dig Howitt | 3,851 | $848,760 | Issued | Issue of securities. 13,065 - Performance Rights & Deferral Performance Rights As per announcement on 06/10/2021. |
07/09/2021 | Dig Howitt | 8,991 | $2,132,934 | Sell | On-market trade. |
03/09/2021 | Dig Howitt | 8,991 | $1,823,734 | Exercise | Exercise of options. |
03/09/2021 | Dig Howitt | 8,991 | $1,823,734 | Buy | Exercise of options. |
25/08/2021 | Christine McLoughlin | 232 | $53,617 | Buy | On-market trade. |
23/08/2021 | Dig Howitt | 1,264 | $305,319 | Cancelled | Cancellation of securities. 9,214 - Performance Rights |
23/08/2021 | Dig Howitt | 3,055 | $737,935 | Buy | Conversion of securities. |
23/08/2021 | Dig Howitt | 26,916 | $6,501,559 | Cancelled | Cancellation of securities. |
23/08/2021 | Dig Howitt | 3,055 | $737,935 | Exercise | Conversion of securities. 10,478 - Performance Rights |
23/08/2021 | Christine McLoughlin | 168 | $40,671 | Buy | On-market trade. |
26/02/2021 | Catriona Deans | 786 | $163,825 | Buy | On-market trade. |
21/10/2020 | Dig Howitt | 4,782 | $1,062,703 | Issued | Issue of securities. 13,533 - Performance Rights |
21/10/2020 | Dig Howitt | 21,217 | $4,715,053 | Issued | Issue of securities. |